Spencer R. Berthelsen, Director at IONIS PHARMACEUTICALS INC (IONS), sold 30,000 shares at $63.37 ($1.9M) on 2019-06-24, disclosed to the SEC on 2019-06-26.
Open-market sale of $1.9M IONS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.37 | 5,310 | $336K | 17.6% |
| 2 | $63.37 | 5,310 | $336K | 17.6% |
| 3 | $63.84 | 9,690 | $619K | 32.4% |
| 4 | $63.84 | 9,690 | $619K | 32.4% |
| Total | $63.67 avg | 30,000 | $1.9M | 100% |
| Filing → |
| IONS | SELL | 2024-06-20 | $645K | — | Filing → |
| IONS | SELL | 2021-06-25 | $566K | — | Filing → |
| IONS | SELL | 2020-06-25 | $881K | — | Filing → |